Histopathology and Nuclear Grading in Renal Cell Neoplasms

  • M. Tannenbaum
  • S. Tannenbaum
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 53)


In most series of renal adenocarcinomas the overall ten year survival rate is between 18 and 27% (1). Considering that nephrectomy is frequently performed under adverse circumstances and in spite of metastasis at the time of surgery, the overall survival is still very high as compared to many other cancers with a similar clinical stage. This supports the belief that these tumors are usually slow growing. The poor prognosis is usually not solely attributable to aggressiveness but rather to the large sizes that these tumors can attain, the frequency of metastases being responsible for the presenting symptomatology, and the extensive delay before the patient seeks medical aid (2).


Renal Cell Carcinoma Renal Vein Renal Tumor Nuclear Grade Renal Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J.J. Kaufman, Reasons for nephrectomy. Palliative and curative, J.A.M.A. 204: 607 (1968).PubMedCrossRefGoogle Scholar
  2. 2.
    J.L. Bennington and J.C. Beckwith, Atlas of Tumor Pathology: Tumors of the Kidney, Renal Pelvis, and Ureter, Armed Forces Institute of Pathology, Washington, D.C. (1975).Google Scholar
  3. 3.
    J.M. Holland, Cancer of the kidney — Natural history and staging, Cancer 32: 1030 (1973).PubMedCrossRefGoogle Scholar
  4. 4.
    C.J. Robson, B.M. Churchill, and W. Anderson, The results of radical nephrectomy for renal cell carcinoma, J. Urol. 101: 297 (1969).PubMedGoogle Scholar
  5. 5.
    I.H. Griffiths, “Monographs on Neoplastic Disease at Various Sites, Vol. V, Tumours of the Kidney and Ureter,” Williams & Wilkins Co., Baltimore (1964).Google Scholar
  6. 6.
    O. Arner, C. Blanck, and T. von Schreeb, Renal adenocarcinoma; morphology-grading of malignancy-prognosis, Acta Chir. Scand. (Suppl.) 346: 1 (1975).Google Scholar
  7. 7.
    S. Kay, Renal carcinoma. A 10-year study, Am. J. Clin, Pathol. 50: 428 (1968).Google Scholar
  8. 8.
    E.T. Bell, “Renal Disease,” Lea & Febiger, Philadelphia (1950).Google Scholar
  9. 9.
    E.W. Riches, “Monographs on Neoplastic Disease at Various Sites, Vol. V, Tumours of the Kidney and Ureter,” Williams & Wilkins Co., Baltimore (1964).Google Scholar
  10. 10.
    M.M. Melicow and A.C. Uson, Nonurologic symptoms in patients with renal cancer, J.A.M.A. 172: 146 (1960).CrossRefGoogle Scholar
  11. 11.
    L.E. Bottiger, C. Blanc, and T. von Schreeb, Renal carcinoma. An attempt to correlate symptoms and findings with the histopathologic picture, Acta Med. Scand. 180: 329 (1966).PubMedCrossRefGoogle Scholar
  12. 12.
    F.K. Mostofi,”Pathology and Spread of Renal Cell Carcinoma,” Little Brown & Co. Inc., Boston (1967).Google Scholar
  13. 13.
    R.H. Flocks and M.C. Kadesky, Malignant neoplasms of the kidney: an analysis of 353 patients followed five years or more, J. Urol. 79: 196 (1958).PubMedGoogle Scholar
  14. 14.
    S.D. Petkovic, An anatomical classification of renal tumors in the adult as a basis for prognosis, J. Urol. 81: 618 (1959).PubMedGoogle Scholar
  15. 15.
    H.R. Newman and M.L. Schulman, Renal cortical tumors: a 40-year study, Urol. Survey 19: 2 (1969).Google Scholar
  16. 16.
    S.A. Fuhrman and C. Limas, Prognostic significance of morphologic parameters in renal cell carcinoma, Lab. Invest. 44: 22A (Abs.) (1981).Google Scholar
  17. 17.
    K.W. Gilchrist, T.F. Hogan, and J. Harberg, Simplified assessment as a prognostic discriminant in renal cell carcinoma, Lab. Invest. 44: 22A (Abs.) (1981).Google Scholar
  18. 18.
    M.M. Lieber, K.M. Tornera, and G.M. Farrow, Renal oncocytoma, J. Urol. 125: 481 (1981).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • M. Tannenbaum
    • 1
  • S. Tannenbaum
    • 1
  1. 1.Columbia-Presbyterian Medical CenterNew YorkUSA

Personalised recommendations